Aspen Neuroscience, Inc.
www.aspenneuroscience.comAspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Read more
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Read more
Country
State
Louisiana
Industry
Employees
11-50
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Bioinformatics
Email ****** @****.comPhone (***) ****-****Senior Vice President , Corporate Affairs
Email ****** @****.comPhone (***) ****-****Senior Vice President Global Regulatory Affairs and Quality
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(17)
Reach decision makers at Aspen Neuroscience, Inc.
Free credits every month!
Aspen Neuroscience, Inc. FAQ
United States
Biotechnology Research
